We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Algeta Signs Exclusive License Agreement with Lumiphore, Inc.

News   May 02, 2013

 
Algeta Signs Exclusive License Agreement with Lumiphore, Inc.
 
 
 

RELATED ARTICLES

Post-heart Attack Antibody Levels May Guide Treatment

News

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity.

READ MORE

Cellular Dumpster-diving Enables Degradation Landscape Exploration

News

A novel technology for profiling protein turnover and degradation offers new insight into diagnosis and understanding the molecular basis of autoimmunity, cancer, neurodegeneration and other disorders.

READ MORE

Is There a Link Between Herpes and Alzheimer's?

News

Possible links between herpes and Alzheimer's disease have been assessed in a recent review.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE